Biotest GmbH & Co. KGaA (HAM:BIO0)
Germany · Delayed Price · Currency is EUR 32.20
-0.10 (-0.31%)
At close: Jun 10, 2026
Biotest GmbH & Co. KGaA Market Cap
Biotest GmbH & Co. KGaA has a market cap or net worth of €1.27 billion as of June 10, 2026.
Market Cap
1.27B
Enterprise Value
1.90B
Revenue
635.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
€32.20
Market Cap Chart
Since January 14, 2025, Biotest GmbH & Co. KGaA's market cap has decreased from 1.37B to 1.27B, a decrease of -6.94%. That is a compound annual growth rate of -5.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 1.28B | -11.26% |
| Dec 30, 2025 | 1.44B | 5.20% |
| Jan 14, 2025 | 1.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Darwin AG | 72.00M |
| 2invest AG | 48.26M |
| Biomark Diagnostics | 35.52M |
| Vidac Pharma Holding | 24.78M |
| co.don AG | 454.30K |
| Paion AG | 399.49K |
| bioXXmed AG | 222.93K |
| MagForce AG | 122.29K |